This study employs model cell lines that overexpress either wild-type FLT4 or the mutant FLT4 variant c.3175G>C to evaluate its functional activity, thereby elucidating the pathogenic role of c.3175G>C in VEGFR3 dysfunction and the development of primary lymphedema. The gene discussed is FLT4; the disease is lymphedema.